$6.27 -$0.09 (-1.4%)

04:00 PM EDT on 09/18/19

Intrexon (NASDAQ:XON)

CAPS Rating: 3 out of 5

Current Price $6.27 Mkt Cap $949.7M
Open $6.35 P/E Ratio 0.00
Prev. Close $6.36 Div. (Yield) -$1.09 (0.0%)
Daily Range $6.15 - $6.47 Volume 1,034,481
52-Wk Range $3.95 - $9.10 Avg. Daily Vol. 41

Caps

How do you think NASDAQ:XON will perform against the market?

Add Stock to CAPS Watchlist

All Players

107 Outperform
5 Underperform
 

All-Star Players

11 Outperform
1 Underperform
 

Wall Street

2 Outperform
0 Underperform
 

Top NASDAQ:XON Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

teachersam (< 20)
Submitted January 19, 2016

It is the largest publicly traded company in the the potential game changing field of synthetic biology that has the potential to offer enormous profits to Intrexon. Kirk owns nearly half the company and is the only one I know who became a… More

DeathStock (65.65)
Submitted July 25, 2016

A Very, Very, High probability that this may Hold a slight touch of scam to it.Praise the Lord - Death

NASDAQ:XON VS S&P 500 (SPY)

Fools bullish on NASDAQ:XON are also bullish on:

Fools bearish on NASDAQ:XON are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about XON.

Recs

0
Member Avatar DCWD40 (40.92) Submitted: 3/1/2019 12:32:55 PM : Outperform Start Price: $5.03 NASDAQ:XON Score: +16.94

Great big-time technology -- priced as if the company was going out of business.

Recs

0
Member Avatar Bigsef77 (67.30) Submitted: 9/24/2018 11:01:33 AM : Outperform Start Price: $14.93 NASDAQ:XON Score: -63.28

Intrexon Announces Advances in Production of Medical Cannabis
PR Newswire PR Newswire•September 24, 2018
Microbial Fermentation of Cannabinoids Provides Advantages over Plant-Based Extraction

BUDAPEST, Hungary, Sept. 24, 2018 /PRNewswire/ -- Intrexon Corporation (XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced advances in the development of its microbial platform to produce cannabinoids for medical uses. Through Intrexon's proprietary technologies, the Company has engineered a yeast strain to produce low-cost, robust and consistent cannabinoid outputs via fermentation. This process utilizing microbes has potential to provide greater supply-chain security, and avoids the resource-intensive isolation that often leads to quality and quantity variability in end products.

Recs

0
Member Avatar tron3 (70.15) Submitted: 3/29/2016 11:07:53 AM : Outperform Start Price: $33.76 NASDAQ:XON Score: -129.77

zika virus

Leaderboard

Find the members with the highest scoring picks in XON.

Score Leader

pbk100

pbk100 (29.16) Score: +150.93

The Score Leader is the player with the highest score across all their picks in XON.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
pbk100 29.16 8/8/2013 Underperform 3Y $24.00 -73.87% +77.06% +150.93 0 Comment
marlie313 29.52 9/23/2013 Underperform 5Y $22.05 -71.57% +76.58% +148.15 0 Comment
GreenAB 38.03 3/5/2015 Underperform 5Y $49.45 -87.32% +42.89% +130.21 0 Comment
wmtworker 79.81 5/14/2019 Outperform 5Y $4.26 +47.18% +6.76% +40.43 0 Comment
capstrarian 90.37 12/17/2018 Underperform 5Y $7.85 -20.13% +17.40% +37.53 0 Comment
DCWD40 40.92 3/1/2019 Outperform 5Y $5.03 +24.65% +7.71% +16.94 1 Comment
drugtrader 89.96 3/12/2019 Outperform 5Y $5.24 +19.66% +7.88% +11.78 0 Comment
mjswanhart13 54.05 3/14/2019 Outperform 5Y $5.61 +11.76% +6.99% +4.77 0 Comment
Bigcaps19 32.11 9/10/2019 Underperform 5Y $5.76 +8.85% +1.24% -7.61 0 Comment
DeathStock 65.65 11/27/2018 Outperform 5Y $9.08 -30.97% +12.64% -43.61 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 86.42 12/12/2014 Outperform 3W $26.92 -76.71% +49.86% -126.56 0 Comment
trackmizuho < 20 9/3/2013 Outperform NS $22.20 -71.76% +82.20% -153.96 0 Comment